新型PAP向的CAR-T疗法通过CoupledCAR方法提高了抗瘤疗效
Zhiyuan Cao1, Chengfei Pu1, Xianyang Jiang1
1Innovative Cellular Therapeutics, Shanghai, China.
Journal for immunotherapy of cancer
|May 31, 2025
概括
这项研究确定了前列腺酸酸酶 (PAP) 作为前列腺癌化学抗原受体 (CAR) -T细胞治疗的特定标. 新的CoupledCAR平台增强了CAR-T细胞扩张和对抗固体瘤的功能,而不需要瘤抗原.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
背景情况:
- 用CAR-T细胞治疗固体瘤面临挑战,原因是瘤特异性标有限,CAR-T细胞扩张/功能差.
- 目前用于前列腺癌的CAR-T疗法缺乏特异性,增加了安全风险.
- 前列腺癌是全球重要的健康问题,需要改进治疗策略.
研究的目的:
- 为了确定前列腺癌CAR-T治疗的特定目标.
- 开发一种用于固体瘤的新型CAR-T细胞扩张平台.
- 评估新治疗方法的疗效和机制.
主要方法:
- 在前列腺癌中使用癌症基因组图谱和免疫组织化学分析了PAP表达.
- 从人类单链抗体库中生成和选择PAP特异性抗体.
- 构建了针对PAP的CAR-T细胞,并评估了体外和体内的抗瘤疗效,包括scRNA-Seq分析.
主要成果:
- PAP 特别表达在前列腺癌细胞中,而不是在其他组织中.
- PAP CAR-T细胞在体外和体内都表现出显著的抗瘤疗效.
- 结合CAR系统有效地扩展了PAP CAR-T细胞,促进了类似记忆的状态,并通过辅助刺激和细胞因子信号增强了抗瘤活性.
结论:
- 前列腺酸酶 (PAP) 是前列腺癌中CAR-T治疗的经过验证的特定标.
- 结合CAR平台技术使瘤向CAR-T细胞的抗原独立扩张成为可能.
- 这种方法增强了CAR-T细胞对固体瘤的功能,提供了一个有前途的新疗法策略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347


